UBM Rating Reiterated by BNP Paribas (UBM)
UBM (LON:UBM)‘s stock had its “outperform” rating restated by analysts at BNP Paribas in a research report issued to clients and investors on Wednesday, StockRatingsNetwork reports. They currently have a GBX 820 ($13.26) target price on the stock. BNP Paribas’ price target would suggest a potential upside of 19.27% from the company’s current price.
A number of other firms have also recently commented on UBM. Analysts at Barclays cut their price target on shares of UBM from GBX 830 ($13.42) to GBX 810 ($13.10) in a research note to investors on Wednesday. They now have an “overweight” rating on the stock. Separately, analysts at JPMorgan Chase & Co. upgraded shares of UBM to an “overweight” rating in a research note to investors on Wednesday. They now have a GBX 815 ($13.18) price target on the stock, down previously from GBX 830 ($13.42). Finally, analysts at Nomura cut their price target on shares of UBM from GBX 860 ($13.91) to GBX 800 ($12.94) in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Eleven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of GBX 795.98 ($12.87).
UBM (LON:UBM) opened at 676.50 on Wednesday. UBM has a 52 week low of GBX 627.00 and a 52 week high of GBX 795.00. The stock’s 50-day moving average is GBX 718.9 and its 200-day moving average is GBX 705.0. The company’s market cap is £1.657 billion.
UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world’s buyers and sellers together at events and online, as well as producing and distributing news and specialist content.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.